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Abstract
We investigated whether household to clinic distance was a risk factor for death on tubercu-
losis (TB) treatment in Malawi. Using enhanced TB surveillance data, we recorded all TB
treatment initiations and outcomes between 2015 and 2018. Household locations were geolo-
cated, and distances were measured by a straight line or shortest road network. We con-
structed Bayesian multi-level logistic regression models to investigate associations between
distance and case fatality. A total of 479/4397 (10.9%) TB patients died. Greater distance
was associated with higher (odds ratio (OR) 1.07 per kilometre (km) increase, 95% credible
interval (CI) 0.99–1.16) odds of death in TB patients registered at the referral hospital, but
not among TB patients registered at primary clinics (OR 0.98 per km increase, 95% CI
0.92–1.03). Age (OR 1.02 per year increase, 95% CI 1.01–1.02) and HIV-positive status
(OR 2.21, 95% CI 1.73–2.85) were also associated with higher odds of death. Model estimates
were similar for both distance measures. Distance was a risk factor for death among patients at
the main referral hospital, likely due to delayed diagnosis and suboptimal healthcare access.
To reduce mortality, targeted community TB screening interventions for TB disease and
HIV, and expansion of novel sensitive diagnostic tests are required.
Introduction
In 2019, tuberculosis (TB) was the leading cause of death from a single infectious disease in the
world, causing more deaths than HIV/AIDS and malaria combined [1]. Slow progress has been
made in reducing TB mortality, and the World Health Organization’s (WHO) End TB strategy
target of achieving a 90% reduction in TB deaths between 2015 and 2030 [1] is unlikely to be
met.
In the WHO Africa (AFRO) region, TB treatment success rates (cured or completed treat-
ment) in 2017 were 86% for HIV-negative people and 78% for HIV-positive people [1].
Despite these improvements from 2007 (when overall TB treatment success was estimated
to be 79% in Africa), a considerable fraction of people with TB symptoms are delayed in acces-
sing TB diagnosis and care at health facilities [1, 2]. The reasons for delayed access to treat-
ment are complex and multi-layered, but include health care-seeking behaviours, clinical
and geographical factors, and suboptimal care quality in health facilities [3].
Distance to health facilities is a well-recognised access barrier to prompt diagnosis [4–7].
Individuals who live far from health facilities are at an increased risk of unfavourable health
outcomes [4–6] and at an increased risk of death on TB treatment [8–10]. However, there
is limited evidence about associations between distance and death on TB treatment in
urban African settings.
Using prospectively collected data from people initiating TB treatment at health facilities in
urban Blantyre, Malawi in the era of high antiretroviral therapy (ART) coverage for HIV, we
hypothesised that people initiating TB care at facilities at greater distances from their homes
might be at greater risk of death on TB treatment compared to people who lived nearer to
clinics. Additionally, as accurate measurement of clinic distance may be challenging under
routine programmatic conditions, we compared distance measurement using two approaches
that could be used by health planners and epidemiologists: Cartesian distance and shortest
road network distance.
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Methods
Study setting and design
Blantyre District is located in the southern region of Malawi.
Blantyre city, in the centre of the district, has large areas of
densely-populated informal settlements. Blantyre’s 2018 census
population was 1 264 304 [11] and HIV prevalence was 18% [12].
Blantyre enhanced TB monitoring and evaluation
In Malawi, patients diagnosed with TB register to receive treatment
at primary health care centres and hospitals. In Blantyre, TB regis-
tration clinics include one referral hospital (Queen Elizabeth
Central Hospital (QECH)), one large private church-supported
clinic (Mlambe), three private clinics and seven government public
primary health care clinics [13]. QECH is a tertiary referral hospital
for the whole southern region of Malawi and offers inpatient care
including TB diagnosis and treatment [13].
In a joint project between the Malawi-Liverpool-Wellcome
Trust Clinical Research Programme, Blantyre District Health
Office and the Malawi National TB Control Programme (NTP),
TB Officers (a cadre of health worker employed by the Ministry
of Health of Malawi) received training to strengthen the TB sur-
veillance system in Blantyre. Since 2015, TB Officers stationed at
TB treatment clinics in Blantyre provided TB treatment, HIV test-
ing and linkage to treatment in accordance with Malawi guide-
lines. They further recorded TB registration data into NTP TB
registers and additionally recorded individual-level clinical, socio-
demographic and household data using an electronic data collec-
tion application (ePaL), which we have previously developed and
validated (18). Using ePaL, TB officers obtained global position-
ing satellite (GPS) coordinates for the location of TB patients’
households (18). A spot sputum sample was also collected from
all patients starting TB treatment (if patients were able to
produce sputum) that underwent smear microscopy and myco-
bacteria growth indicator tube culture. On a quarterly basis,
study and TB programme registers were reconciled.
TB outcomes were defined according to mutually-exclusive
WHO TB treatment outcome definition guidelines [14], with
patients classified as either cured, completed treatment, treatment
failed, confirmed died, lost to follow-up or not evaluated (typic-
ally because still on treatment). The outcome of interest for this
analysis was confirmed death on TB treatment; we did not
follow-up patients to confirm death. The analysis was limited to
study participants that were registered for treatment from 1
January 2015 to 30 December 2018.
Statistical analysis
Baseline characteristics
We compared the characteristics of participants, recorded at TB
treatment registration, between those who died during TB treat-
ment and those who were alive at the end of treatment. For categor-
ical variables, we calculated percentages and used the χ2 test for
comparisons; for continuous variables, we calculated medians
(and interquartile ranges (IQR)), mean (and standard deviation)
and compared between groups using the Kruskal–Wallis test.
Distance estimation
We estimated the distance from study participants’ households
to their TB treatment initiation clinic using two approaches
(Fig. 1). The first approach was to estimate the distance
based on a ‘straight line’ distance (Cartesian distance). In the
second approach, we used Blantyre urban road network down-
loaded from OpenStreetMap (OpenStreetMap Foundation) to
calculate the shortest road network distance using the stplanr
R package [15].
Statistical models
To estimate the causal relationship between clinic distance and TB
case fatality, we constructed a directed acyclic graph (Fig. 2). The
minimum adjustment set of confounders identified from the
DAG were: sex, age, HIV, hospital admission (QECH) and house-
hold wealth score. We included a term for the interaction between
household to clinic distance and the clinic at which TB registra-
tion occurred (QECH, the city’s referral hospital, vs. other pri-
mary health care centres). This was because QECH is a large
referral hospital known to have a patient population with more
advanced TB disease, more complicated TB disease and patients
that are likely to have travelled a longer distance compared to
patients that attend other clinics.
Using asset ownership data, we created a household wealth
score variable, calculated using a proxy means test developed
for urban populations from the Malawi Integrated Household
Survey [16]. Individuals for whom components needed to calcu-
late their wealth score were missing; their wealth score was
imputed using multiple interval imputation, with the observed
wealth score providing the lower bound.
We constructed Bayesian multi-level logistic regression models
(Equation 1) to investigate the association between participants’
household to clinic distance and their risk of death, adjusting
for confounders and an interaction between household to clinic
distance and clinic of registration. Weakly regularising priors,
refined by inspecting prior predictive plots, were assigned to
model intercepts and slopes. Model convergence was assessed
by visual inspection of trace plots, effective sample numbers
and Gelman–Rubin statistics.
Dij  Binomial(1, pij)
logit( pij) = aclinic of registration j + bsex ij ++bage ij+
bwealthscore ij + bdistance ij + bQECH ij + bdistanceij∗QECH ij
PRIORS
bsex  Normal(0, 0.5)
bage  Normal(0, 0.5)
bhivstatus  Normal(0, 1)
bwealthscore  Normal(0, 0.5)
bdistance  Normal(0, 0.5)
bQECH  Normal(0, 0.5)
bdistance∗ QECH  Normal(0, 0.5)
bclinic of registration j  a+ uj
a  Normal(0, 0.5)
uj  Normal(0, sa)
sa  HalfNormal(0, 0.5)
(1)
where Dij indicates death on TB treatment for the i
th patient in
clinic j, sex indicates sex (male or female), age indicates age in
years, hivstatus indicates HIV status (positive or negative),
wealthscore indicates household wealth score, distance indicates
distance to clinic in kilometres, and QECH indicates whether
2 McEwen Khundi et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0950268821001862
Downloaded from https://www.cambridge.org/core. London School of Hygiene & Tropical Medicine, on 06 Sep 2021 at 17:00:06, subject to the Cambridge Core terms of use, available at
participant registered for treatment at QECH or the other
primary health centres, distance×QECH is the interaction effect
between distance and QECH and clinic of registration
indicates registering for treatment at the jth TB treatment
registration health centre.
Four thousand samples with a warm up of 600 iterations were
drawn from each model posterior distribution using Markov
Chain Monte Carlo methods implemented within Stan via the
brms R package [17]. Posterior means and 95% credible intervals
(CI) were calculated on the log-odds scale and were exponentiated
to give odds ratios. In sensitivity analysis, we refitted models
recoding participants who were lost to follow-up or transferred
out during TB treatment as having died since it was possible
that some of these patients had actually died [18]. Additionally,
we restricted the analysis to those with microbiologically-
confirmed TB. To investigate the predictive accuracy of the two
distance estimates, we used models that just had distance and
the interaction effect of distance and registering for TB treatment
at QECH. We plotted the difference in the predicted probability of
death for the 100 patients with the greatest difference in distance
from the two measurement methods. Analysis was conducted
using R version 3.5.2 (R Foundation for Statistical Computing,
Vienna).
Ethical considerations
Ethical approval was granted by the London School of Hygiene
and Tropical Medicine (16228) and the College of Medicine,
University of Malawi Research Ethics Committee (P.12/18/
2556). Participants provided oral consent to participate in TB sur-




A total of 4461/5199 (85.8%) patients that initiated TB treatment
at the 12 study clinics were included in this analysis. In total, 64/
4461 (1.4%) had a missing TB outcome and were excluded from the
Fig. 1. Illustration of the two methods for the measurement of household to clinic distance: Cartesian distance (2.7 km), shortest road network distance (4.5 km).
Note: The patient place of residence is a randomly generated point for illustration and does not correspond to any patient in the dataset.
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primary analysis (Appendix Table A1). Among participants that
had treatment outcomes, 479/4397 (10.9%) died while taking TB
treatment, and 258/4397 (5.9%) were reported as lost to follow-up
or transferred out (Table 1). The percentage of participants who
died did not substantially differ across the study years (P = 0.313).
More deaths were reported among participants who initiated
TB treatment at QECH (315/2170, 14.5%) than in the other 11
TB clinics (164/2227, 7.4%, P < 0.001; Table 1). Similar percen-
tages of men (303/2789, 10.9%) and women (176/1608, 10.9%,
P = 0.934) died during TB treatment. The median age of partici-
pants who died was older (median: 37 years, IQR: 30.0–45.0)
compared to those who were alive at the end of TB treatment
(35 years, IQR: 28.0–41.0, P < 0.001). A higher proportion of
deaths occurred in patients who were HIV-positive (400/2981,
13.4%) compared to HIV-negative (79/1416, 5.6%, P < 0.001).
Participants who did not have a microbiologically-confirmed
TB (318/2382, 13.4%) were considerably more likely to die com-
pared to participants with either sputum smear, Xpert or culture-
positive disease (161/2015, 8.0%, P < 0.001).
The median road network household to clinic distance
(median: 5.2 km, IQR: 3.2–7.7) was consistently higher than the
Cartesian household to clinic distance estimates (median: 3.8
km, IQR: 2.1–5.9). Both household to clinic distance estimates
showed that patients who died on TB treatment lived further
from clinics where they initiated TB treatment than those that
were alive at the end of TB treatment. For the road network dis-
tance measure, those who died on TB treatment had greater clinic
distances (median: 5.8 km, IQR: 4.1–9.0) compared to participants
who were still alive at TB treatment completion (median: 5.1 km,
IQR: 3.1–7.5, P < 0.001). Likewise, those who died on TB treatment
had a longer Cartesian distance (median: 4.4 km, IQR: 2.9–6.8) vs.
participants who were still alive at the end of TB treatment
(median: 3.8 km, IQR: 2.0–5.7, P < 0.001). Patients who did not
live within geographically-mapped areas of the city were excluded
738/5199 (14.2%) because we did not have data to ascertain their
household location, and so could not calculate their household to
clinic distance (Appendix Table A1).
Unadjusted analysis of the association of household to clinic
distance and risk of death
TB patients who lived further from the clinic at which they regis-
tered for treatment had higher odds of death compared to those
who lived nearer, whether measured by the road network distance
method (odds ratio (OR) 1.05 per km increase, 95% CI 1.03–1.08)
or the Cartesian distance method (OR 1.06 per km increase, 95%
CI 1.03–1.09; Table 2).
Unadjusted analysis for confounders
In unadjusted analysis, each one year increase in age was associated
with a 2% increase (OR 1.02, 95% CI 1.01–1.02) in the odds of
death. Being HIV-positive was associated with a 2.5-times (OR vs.
HIV-negative status 2.53, 95% CI 2.0–3.25) increase in the odds
of death on TB treatment. TB patients who registered at QECH
had two times higher (OR 2.10, 95% CI 1.74–2.56) odds of death
compared to people registering at the other primary clinics. Each
Fig. 2. Directed acyclic graph (causal diagram). Illustrating the relationship between distance to TB clinic and risk of death on TB treatment and other covariates.
The variables sex, age, HIV, Queens Elizabeth hospital registration (QECH) vs. registration at other clinics and poverty were selected as the minimum adjustment set.
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one-unit increase in wealth score was associated with a 40% (OR
1.40, 95% CI 0.98–2.04) increase in the odds of death.
Adjusted analysis for household to clinic distance models
Greater household to clinic distance (road network) had a higher
odds of death in TB patients registered at QECH (OR 1.07 per km
increase, 95% CI 0.99–1.16), but was not associated with odds of
death in TB patients registered at other clinics (OR 0.98 per km
increase, 95% CI 0.92–1.03). The average risk of death varied
between clinics by 6% (95% CI 4–11%) holding categorical
variables at their base level and continuous variables at their
average value, with a standard deviation of 0.67 (0.32–1.18;
Table 2).
For the model containing Cartesian distance to clinic, model
coefficients and uncertainty bounds were very similar to those
from the road distance model, with distance from household to
clinic of treatment registration associated with higher odds of
death in TB patients registered at QECH (OR 1.09 per km
increase, 95% CI 1.0–1.21), but was not associated with odds of
Table 1. Characteristics for notified tuberculosis cases in urban Blantyre Malawi, 2015–2018
Alive (N = 3918) Died (N = 479) Total (N = 4397) P-value
Year of registration 0.313
2015 860 (89.1%) 105 (10.9%) 965 (100.0%)
2016 1187 (89.5%) 139 (10.5%) 1326 (100.0%)
2017 1238 (88.0%) 169 (12.0%) 1407 (100.0%)
2018 633 (90.6%) 66 (9.4%) 699 (100.0%)
Gender 0.934
Female 1432 (89.1%) 176 (10.9%) 1608 (100.0%)
Male 2486 (89.1%) 303 (10.9%) 2789 (100.0%)
Age, years <0.001
Median (IQR) 35.0 (28.0, 41.0) 37.0 (30.0, 45.0) 35.0 (28.0, 42.0)
Mean (SD) 35.1 (13.4) 38.3 (13.7) 35.4 (13.4)
HIV status <0.001
Negative 1337 (94.4%) 79 (5.6%) 1416 (100.0%)
Positive 2581 (86.6%) 400 (13.4%) 2981 (100.0%)
TB classification <0.001
Extrapulmonary TB 1375 (85.5%) 233 (14.5%) 1608 (100.0%)
Pulmonary TB 2543 (91.2%) 246 (8.8%) 2789 (100.0%)
Micro confirmed TB <0.001
Not microbiologically-confirmed TB 2064 (86.6%) 318 (13.4%) 2382 (100.0%)
Microbiologically-confirmed TB 1854 (92.0%) 161 (8.0%) 2015 (100.0%)
Distance km (Cartesian) <0.001
Median (IQR) 3.8 (2.0, 5.7) 4.4 (2.9,6.8) 3.8 (2.1, 5.9)
Mean (SD) 4.3 (3.1) 4.9 (3.1) 4.3 (3.1)
Distance km (road network) <0.001
Median (IQR) 5.1 (3.1, 7.5) 5.8 (4.1, 9.0) 5.2 (3.2, 7.7)
Mean (SD) 5.7 (3.7) 6.5 (3.7) 5.8 (3.7)
Wealth scorea 0.461
Missing 3446 417 3863
Median (IQR) 2.5 (2.2, 3.0) 2.6 (2.2, 3.1) 2.5 (2.2, 3.0)
Mean (SD) 2.6 (0.5) 2.6 (0.6) 2.6 (0.5)
Clinic of registration <0.001
Other clinics 2063 (92.6%) 164 (7.4%) 2227 (100.0%)
Queen Elizabeth Central Hospital 1855 (85.5%) 315 (14.5%) 2170 (100.0%)
HIV, human immunodeficiency virus; km, kilometres; (Q1, Q3) interquartile range; SD, standard deviation; TB, tuberculosis.
aWealth score, household wealth developed using household asset ownership.
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Sex (male) 0.99 (0.81–1.21) 1.06 (0.87–1.29) 1.06 (0.87–1.30)
Age (years)c 1.02 (1.01–1.02) 1.02 (1.01–1.02) 1.02 (1.01–1.02)
HIV positive 2.53 (2.00–3.25) 2.21 (1.73–2.85) 2.21 (1.73–2.86)
Wealth scorec,d 1.40 (0.98–2.04) 1.15 (0.80–1.73) 1.14 (0.80–1.72)
Queen Elizabeth Central Hospital 2.10 (1.74–2.56)
Network distance (km)c 1.05 (1.03–1.08)
Cartesian distance (km)c 1.06 (1.03–1.09)
Road network distance 1.02 (0.99–1.06) 0.98 (0.92–1.03)
Queen Elizabeth Central Hospital 1.93 (1.57–2.38) 2.00 (0.93–4.25)
Network distance (km)×Queen Elizabeth Central
Hospital
1.02 (0.96–1.08)e 1.07 (0.99–1.16)
Cartesian distance 1.03 (0.99–1.07) 0.97 (0.89–1.04)
Queen Elizabeth Central Hospital 1.91 (1.55, 2.35) 2.00 (0.92–4.27)
Cartesian distance (km)×Queen Elizabeth Central
Hospital
1.03 (0.96–1.11)f 1.09 (1.00–1.21)
Clinic of registration intercept 0.06 (0.04–0.11) 0.06 (0.04–0.11)
Clinic of registration intercept standard deviation 0.67 (0.32–1.18) 0.69 (0.33–1.19)
km, Kilometres; OR, odds ratio.
The analysis was done for all the data at once (N = 4397) using Bayesian multi-level logistic regression models.
a,bAdjusted for sex (male vs. female), age in years, HIV status (HIV-positive vs. HIV-negative), wealth score the household wealth score, TB treatment registration at Queen Elizabeth Central
Hospital (QECH) vs. the other health care facilities, distance household to clinic distance in kilometres, distance (km)×QECH interaction effect of QECH and household to clinic distance and a
term for the random intercept of clinic of registration.
cAge in years, household to clinic distance and household wealth score were centred by subtracting the mean.
dWealth score of household wealth developed using household asset ownership.
e,fAdjusted for TB treatment registration at QECH vs. other health care facilities, household to clinic distance, and the interaction effect of QECH and household to clinic distance.
Fig. 3. Plot of difference between shortest road network
and Cartesian distance, vs. fitted probability of death, for
the 100 notified TB cases with the largest distance differ-
ences. q, Queen Elizabeth Central Hospital; m, Mlambe
Private Hospital; l, Limbe Health Centre; g, Bangwe
Health Centre; z, Zingwangwa Health Centre; a,
Blantyre Adventist Hospital; c, Chilomoni Health Centre.
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death on TB treatment in patients registered at other clinics (OR
0.97 per km increase, 95% CI 0.89–1.04).
Comparison of model predicted risk of death among 100
participants with biggest difference between their road
network distance and Cartesian distance estimates
The majority of the 100 TB patients with the greatest difference in
distance between the two household to clinic distance measure-
ments registered for treatment at QECH or Mlambe private clinic
(Fig. 3). For these participants who had the greatest measurement
difference, there was, as expected, a trend of increased difference
in probability of death with a greater difference between the two
distance measures. The greatest differences were seen at Mlambe
private clinic, reflecting greater distances travelled by road.
However, the maximum difference in the predicted probability
of death over these 100 patients was only 0.79%.
Sensitivity analysis
When we reclassified TB patients who were lost to follow-up or
had transferred out during TB treatment as having died, model
estimates were very similar to our primary analysis (Table 3).
Analysis restricted to participants with microbiologically-
confirmed disease did not alter our model conclusion (Table 4).
Discussion
Our primary hypothesis was that greater household to clinic
distance would be associated with an increased risk of death for
people starting treatment for TB in urban Blantyre, Malawi.
The results of the pre-specified unadjusted analysis showed clinic
distance was a risk factor for death after starting TB treatment.
However, in adjusted analysis based on our causal graph, greater
clinic distance was a risk factor for death only for participants
initiating care at the tertiary referral hospital (QECH).
Treatment initiation at the city’s tertiary hospital, older age and
HIV-positive status were important predictors of death whilst tak-
ing TB treatment. We additionally found moderate variation in
the risk of death between treatment clinics that was not explained
by TB patient clinical and socio-demographic characteristics,
indicating that clinic quality of care might be an important
residual determinant of treatment outcomes.
We used two different measures (Cartesian distance, and
shortest road network distance) of household to clinic distance
that could be applied by public health planners and epidemiolo-
gists, recognising that road network distance may be considerably











Sex (male) 1.10 (0.94–1.28) 1.06 (0.87–1.29) 1.06 (0.87–1.29)
Age (years)c 1.01 (1.01–1.02) 1.02 (1.01–1.03) 1.02 (1.01–1.03)
HIV positive 1.76 (1.47–2.11) 2.21 (1.73–2.85) 2.21 (1.73–1.84)
Wealth scorec,d 1.39 (0.97–2.04) 1.15 (0.80–1.72) 1.15 (0.80–1.72)
Queen Elizabeth Central Hospital 1.44 (1.23–1.68)
Network distance (km)c 1.03 (1.01–1.05)
Cartesian distance (km)c 1.01 (0.98–1.05)
Road network distance 1.02 (0.99–1.04) 0.98 (0.92–1.03)
Queen Elizabeth Central Hospital 1.37 (1.16–1.64) 2.02 (0.94–4.31)
Network distance (km)×Queen
Elizabeth Central Hospital
1.01 (0.96–1.07)e 1.07 (0.99–1.16)
Cartesian distance 1.02 (0.99–1.05) 0.97 (0.89–1.04)
Queen Elizabeth Central Hospital 1.37 (1.17–1.61) 2.00 (0.92–4.26)
Cartesian distance (km)×Queen
Elizabeth Central Hospital
1.02 (0.96–1.09)f 1.09 (1.00–1.21)
Clinic of registration intercept 0.06 (0.04–0.11) 0.06 (0.04–0.11)
Clinic of registration intercept standard
deviation
0.68 (0.33–1.17) 0.69 (0.33–1.19)
km, Kilometres; OR, odds ratio.
The analysis was done for all the data at once (N = 4397) using Bayesian multi-level logistic regression models with participants that defaulted and those that transferred out (N = 258)
recoded as died.
a,bAdjusted for sex (male vs. female), age in years, HIV status (HIV-positive vs. HIV-negative), wealth score the household wealth score, TB treatment registration at Queen Elizabeth Central
Hospital (QECH) vs. other health care facilities, distance household to clinic distance in kilometres, distance (km)×QECH interaction effect of QECH and household to clinic distance and a
term for the random intercept of clinic of registration.
cAge in years, household to clinic distance and household wealth score were centred by subtracting the mean.
dWealth score of household wealth developed using household asset ownership.
e,fAdjusted for TB treatment registration at QECH vs. other health care facilities, household to clinic distance, and the interaction effect of QECH and household to clinic distance.
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more challenging to estimate under routine programmatic condi-
tions. Our analysis found that models using either distance meas-
urement reached very similar conclusions, and therefore we
recommend that in low-resource settings, the simpler measure-
ment (Cartesian distance) should likely be more appropriate for
routine programme use.
For TB patients that were treated at the city’s tertiary hospital
(QECH), greater household to clinic distance might be a proxy for
lack of access to quality health care service [8, 19]. Individuals
who live in the peri-urban areas far from the centre of Blantyre
have limited resources for transport, and may struggle to access
timely tertiary-level health care compared to those living nearer
to the centre of the city [20]. Delayed presentation for care will
then result in admission to hospital with more advanced disease
and at a higher risk of death [5, 21].
To reduce the high risk of death on TB treatment, prompt
diagnosis and treatment for people presenting to health facilities
is required [21, 22]. At health facilities in high HIV-prevalence
settings, TB symptoms are common (up to 60% reporting at
least one of the WHO four cardinal TB symptoms) [23].
Therefore, novel screening approaches – including triage testing
using high sensitivity initial tests such as chest X-ray or
C-reactive protein, followed by highly specific tests such as
Xpert for those who triage test positive, require evaluation [5, 24].
QECH is a tertiary referral hospital, and most patients treated
for TB at QECH will have previously sought diagnosis – likely on
multiple occasions before referral – at a primary health centre
[25]. Consequently, earlier diagnosis in primary health care
could reduce hospital admission and potentially reduce mortality
[1]. We need to improve the TB diagnostic capacity of primary
health facilities in the outskirts of the city and ensure that primary
health care facilities can make prompt referrals for hospital care
where required [1, 5, 8].
In addition, there is a need to evaluate community interven-
tions of TB screening in areas further away from the centre of
the city (QECH) since prevalent cases identified in community
interventions are usually diagnosed at an earlier stage of disease
[1, 5]. Our previous work has shown that TB case notifications
decline with greater distance from the centre of Blantyre city;
this might be because of lack of access to quality health care,
including TB diagnosis, at areas in the periphery of the city
[20]. Health promotion activities to promote early treatment seek-
ing, and quality improvement activities with health workers to
support early diagnosis and reduce variation in practice between
clinics could contribute to reduced TB case fatality, whilst
strengthening universal healthcare provision within health facil-
ities [1, 5].
Malawi has made tremendous progress towards achieving the
WHO 90-90-90 HIV targets [26]: 90% of individuals with HIV
are aware of their HIV status, 79% of individuals with a diagnosis
are on ART and 72% of individuals on ART treatment have viral
suppression [27]. Nevertheless, in this study, HIV-positive status











Sex (male) 0.93 (0.69–1.28) 0.99 (0.72–1.38) 0.99 (0.72–1.38)
Age (years)c 1.02 (1.00–1.03) 1.01 (1.00–1.03) 1.01 (1.00–1.03)
HIV positive 3.06 (2.12–4.59) 2.65 (1.79–4.06) 2.66 (1.78–4.03)
Wealth scorec,d 1.85 (0.95–3.49) 1.63 (0.84–3.04) 1.62 (0.84–3.37)
Queen Elizabeth Central Hospital 2.22 (1.62–3.04)
Network distance (km)c 1.07 (1.02–1.11)
Cartesian distance (km)c 1.06 (0.98–1.14)
Road network distance 0.97 (0.88–1.04) 0.97 (0.88–1.04)
Queen Elizabeth Central Hospital 1.67 (0.86–3.42) 1.67 (0.86–3.42)
Network distance (km)×Queen
Elizabeth Central Hospital
1.14 (1.01–1.29)e 1.14 (1.01–1.29)
Cartesian distance 1.01 (0.94–1.08) 0.98 (0.87–1.06)
Queen Elizabeth Central Hospital 1.73 (1.18–2.43) 1.66 (0.86–3.37)
Cartesian distance (km)×Queen
Elizabeth Central Hospital
1.14 (1.00–1.29)f 1.16 (1.01–1.35)
Clinic of registration intercept 0.04 (0.02–0.09) 0.04 (0.02–0.0.09)
Clinic of registration intercept
standard deviation
0.45 (0.02–1.22) 0.43 (0.02–1.20)
km, Kilometres; OR, odds ratio.
The analysis was done using N = 2015 participants that had a microbiologically confirmed TB diagnosis using Bayesian multi-level logistic regression models.
a,bAdjusted for sex (male vs. female), age in years, HIV status (HIV-positive vs. HIV-negative), wealth score the household wealth score, TB treatment registration at Queen Elizabeth Central
Hospital (QECH) vs. the other health care facilities, household to clinic distance in kilometres, distance (km)×QECH interaction effect of QECH and household to clinic distance and a term for
the random intercept of clinic of registration.
cAge in years, household to clinic distance and household wealth score were centred by subtracting the mean.
dWealth score of household wealth developed using household asset ownership.
e,fAdjusted for TB treatment registration at QECH vs. other health care facilities, household to clinic distance, and the interaction effect of QECH and household to clinic distance
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remained strongly associated with an increased risk of death dur-
ing TB treatment. Nearly all TB patients in this study were aware
of their HIV-positive status, and 89% were taking ART at TB
treatment initiation. Persistently high case fatality for
HIV-positive people despite high ART coverage suggests that
HIV-positive people have severe acute illness [28], have profound
delays in TB diagnosis and treatment initiation [29, 30], or have
virological failure to HIV treatment, which itself confers a high
risk of death. In a study among HIV-positive people taking
ART who were admitted to hospital in Zomba District, Malawi
(32%) had virological treatment failure, and resistance to first-line
ART drugs was near-universal [31]. Improvements in viral load
monitoring and rapid treatment changes linked to supportive
adherence interventions could reduce the number of patients
that present with severe disease at the start of TB treatment and
save more lives [31, 32]. Additionally, implementation of
point-of-care HIV viral load monitoring for people living with
HIV who are admitted to hospital could identify treatment failure
earlier. Following WHO recommendations, the Malawi National
HIV Programme has recommended that all people living with
HIV take a Dolutegravir containing regimen, including by switch-
ing treatment regimens for those already taking [31, 33]. It will be
important to investigate the effect of this change on TB case fatal-
ity among patients treated at primary clinics and in hospital
(QECH) [33].
A key strength of this study was that we used prospectively col-
lected data at TB registration through our citywide enhanced TB
surveillance system. Our routine monitoring and evaluation show
consistently very high agreement with national TB treatment reg-
isters. We additionally captured TB patients’ household GPS
coordinates at the point of registration for TB treatment; most
previous studies have attempted to retrospectively geolocate
patients’ households using physical addresses, a method that is
prone to error [34, 35]. Our analysis of household to clinic
distance was analysed at a continuous scale rather than on a
transformed categorical scale with arbitrary value cut-off points
[36, 37]. To investigate the causal relationship between household
to clinic distance and risk of death, we selected confounding
variables for adjustment by constructing a directed acyclic
graph [38]. Sensitivity analysis restricted to TB patients with
microbiologically-confirmed TB and where patients who were
lost to follow-up or transferred out to another clinic did not
alter our findings. However, timing of death was not collected
meaning survival analysis could not be done. A small number
of TB patients may not have been able to accurately geolocate
their household, or may have deliberately misidentified their
household; monthly quality assurance checking of a 5% random
sample of households attempted to mitigate this. While
Appendix Table A1 indicates that TB patients registering for treat-
ment who were residents in the areas of the city not mapped by
our GPS had some different characteristics compared to those liv-
ing in the mapped areas. Nevertheless, the main objective of this
analysis was to predict TB case fatality using data obtained at
treatment registration and there is no reason to believe that the
underlying relationships should differ between those included
and excluded.
In conclusion, in prespecified multilevel modelling using
citywide enhanced surveillance data linked to our satellite GPS
location system, we found that household to clinic distance was
associated with increased risk of death for a patient starting TB
treatment at the city’s central hospital. This could be explained
by barriers in accessing prompt diagnosis and treatment, and
by variable quality of care at primary health facilities.
HIV-positive status and older age remain important risk factors
for death. Therefore, interventions that improve access to TB diag-
nosis through community-based active case finding, and
improved quality of health facility TB screening, and prioritise
HIV-positive people with potentially high levels of viral failure
for TB screening and ART optimisation are required to reduce
the unacceptably high case fatality.
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Appendix
Table A1. Characteristics for notified Tuberculosis cases in Urban Blantyre Malawi, 2015–2018. Comparing participants who were included in the study versus those
who were not part of the study but were from Blantyre.
In study (N = 4461) Not in study (N = 738) Total (N = 5199)
Year of registration
2015 966 (21.7%) 149 (20.2%) 1115 (21.4%)
2016 1330 (29.8%) 191 (25.9%) 1521 (29.3%)
2017 1437 (32.2%) 222 (30.1%) 1659 (31.9%)
2018 728 (16.3%) 176 (23.8%) 904 (17.4%)
Gender
Male 2827 (63.4%) 405 (54.9%) 3232 (62.2%)
Female 1634 (36.6%) 333 (45.1%) 1967 (37.8%)
Age, years
Median (Q1, Q3) 35.0 (28.0, 42.0) 35.0 (21.3, 45.0) 35.0 (27.0, 42.0)
Mean (SD) 35.5 (13.4) 34.2 (19.0) 35.3 (14.4)
HIV status
HIV negative 1428 (32.0%) 333 (45.1%) 1761 (33.9%)
HIV positive 3033 (68.0%) 405 (54.9%) 3438 (66.1%)
TB classification
Extrapulmonary TB 1637 (36.7%) 466 (63.1%) 2103 (40.5%)
Pulmonary TB 2824 (63.3%) 272 (36.9%) 3096 (59.5%)
Micro confirmed TB
Not microb-confirmed TB 2420 (54.2%) 621 (84.1%) 3041 (58.5%)
Microb-confirmed TB 2041 (45.8%) 117 (15.9%) 2158 (41.5%)
TB treatment outcome
N-Miss 64 15 79
Cured 916 (20.8%) 31 (4.3%) 947 (18.5%)
Treatment completed 2715 (61.7%) 419 (58.0%) 3134 (61.2%)
Died 479 (10.9%) 94 (13.0%) 573 (11.2%)
Treatment failure 29 (0.7%) 2 (0.3%) 31 (0.6%)
Lost to follow up 258 (5.9%) 177 (24.5%) 435 (8.5%)
Clinic of registration
Other clinics 2257 (50.6%) 113 (15.3%) 2370 (45.6%)
Queen Elizabeth Central Hospital 2204 (49.4%) 625 (84.7%) 2829 (54.4%)
Abbreviations: HIV, Human immunodeficiency virus; (Q1, Q3) interquartile range; SD standard deviation; TB tuberculosis
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